prazosin has been researched along with Spinal Neoplasms in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Spinal Neoplasms: New abnormal growth of tissue in the SPINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakibara, R | 1 |
| Uchiyama, T | 1 |
| Yoshiyama, M | 1 |
| Aotsuka, A | 1 |
| Mori, M | 1 |
| Kanesaka, T | 1 |
| Hattori, T | 1 |
| Yamanishi, T | 1 |
1 other study available for prazosin and Spinal Neoplasms
| Article | Year |
|---|---|
Micturitional disturbance in a patient with a spinal cavernous angioma.
Topics: Adrenergic alpha-Antagonists; Electromyography; Female; Hemangioma, Cavernous; Humans; Magnetic Reso | 2003 |